Ester Sanchez-Gonzalez
Salamanca, CL 37007, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Corrigendum to: "The endonuclease MCPIP1 protects against liver cancer development in a sex-dependent manner by modulating β-catenin and CREB1" [JHEP Reports 8 (2026) 101755].
Journal: JHEP reports : innovation in hepatology
Published: July 08, 2026
Correction: Gonzalez-Sanchez et al. Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential. Int. J. Mol. Sci. 2025, 26, 11135.
Journal: International journal of molecular sciences
Published: June 22, 2026
Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study.
Journal: Acta pharmacologica Sinica
Published: December 19, 2025
Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 17, 2025
Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential.
Journal: International journal of molecular sciences
Published: September 15, 2025
The endonuclease MCPIP1 protects against liver cancer development in a sex-dependent manner by modulating β-catenin and CREB1.
Journal: JHEP reports : innovation in hepatology
Published: May 16, 2025
New Experimental Mouse Models to Evaluate the Role of Transforming Growth Factor-Beta in Liver Tumorigenesis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 25, 2025
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer.
Journal: Seminars in liver disease
Published: March 05, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts.
Journal: Signal transduction and targeted therapy
Published: September 02, 2024
Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression.
Journal: Cell death & disease
Published: May 06, 2024
Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude Mice.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 05, 2024
Last Updated: 09/26/2026